New Forums to focus on orphan diseases, personalized medicine, regenerative medicine and vaccines
March 13, 2014
The Biotechnology Industry Organization (BIO) today announced Specialty Forums that will highlight the most pressing health issues facing our industry at the 2014 BIO International Convention® in San Diego . The Convention, June 23-26, attracts the biggest names in biotech, offers key networking and partnering opportunities and provides insights and inspiration on major trends affecting the industry. New at BIO 2014, programming will take place for three full days from Tuesday, June 24th through Thursday, June 26th.
“Today, the biotech industry is faced with more promise and greater challenges than we have seen in years. As a result of these challenges, the Convention has designed a series of new Specialty Forums which will offer in-depth conversations and unique perspectives from top business leaders and scientists working to develop the next generation of miracle medicines,” said Scott Whitaker, President of the BIO International Convention. “These new, highly-focused and interactive forums will not only provide great educational content, but will culminate in a unique and dedicated time for collaboration and networking with your industry peers. We are excited that these new session formats will offer an improved three-day Convention educational experience.”
Sponsored by CSL Behring and Genzyme, a Sanofi company, the Orphan Disease Forum, June 24, will provide a unique perspective on the international orphan drug marketplace, new and emerging funding models, the vital role of patient advocacy organizations and the scientific and regulatory considerations for orphan drug development.
The Regenerative Medicine Forum, June 25, will delve into the ways stem cell science and regenerative medicine are impacting the biotechnology and pharmaceutical industries as well as the reasons why the reimbursement community has started to watch the developments in this rapidly emerging field. New for BIO 2014, the California Institute for Regenerative Medicine will sponsor this forum.
Spanning June 25-26, the Personalized Medicine & Diagnostics Forum and the Vaccines & Immunotherapeutics Forum will hear from business thought leaders from Ernst & Young, Roche and Foundation Medicine as well as key partners such as the Bill and Melinda Gates Foundation and the European Commission.
Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here.
For registration, schedule at a glance and exhibitor information, visit 2014 BIO International Convention®. Once registered, search all attendees, sessions, events, exhibitors, partnering companies and more with myBIO.
For more information click here.